(Q61684771)
Statements
Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin (English)
M A Nauck
S Durán-García
K Rohwedder
A M Langkilde
J Sugg